Cytek® Biosciences Names William McCombe Chief Financial Officer
March 19, 2024 08:00 ET
|
Cytek Biosciences, Inc.
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek...
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
March 07, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has opened a 50,000-square-foot facility in Wuxi, China to meet the growing worldwide demand for comprehensive cell analysis solutions
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 28, 2024 17:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 07, 2024 16:10 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 07, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the fourth...
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
January 17, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has signed an agreement with The Centre for Genomic Regulation and the Pompeu Fabra University to accelerate scientific discoveries.
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
January 08, 2024 09:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the...
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
December 21, 2023 09:00 ET
|
Cytek Biosciences, Inc.
The new Cytek Orion reagent cocktail preparation system simplifies & accelerates laboratory workflow, assures consistent experimental results & saves time.
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...